Status:

RECRUITING

A Type I Hybrid Effectiveness-Implementation Trial of MIO

Lead Sponsor:

Baystate Medical Center

Collaborating Sponsors:

Behavioral Health Network

Spectrum Health Systems

Conditions:

Substance Use Disorder

Eligibility:

FEMALE

18+ years

Phase:

NA

Brief Summary

Mothers with substance use disorders face unprecedented stress in their roles as parents working to care for their children while maintaining healthy recovery. Mothering from the Inside Out (MIO) is t...

Detailed Description

Pregnancy and parenting can be life-changing motivators for women with substance use disorders (SUDs) to seek treatment. However, the rate of relapse and overdose for women with SUDs increases sharply...

Eligibility Criteria

Inclusion

  • Client Subjects
  • Identifies as a woman
  • English-speaking
  • Age 18 years or older
  • Enrolled in outpatient substance use treatment for a substance use disorder (by DSMV criteria) at one of the four target clinics operated by participating agencies
  • Caring for at least one child between 0 and 60 months of age (either as guardian or working towards reunification with regular contact)

Exclusion

  • Have severe mental health problems (e.g., actively suicidal, homicidal, psychosis)
  • Severely cognitively impaired
  • Have psychiatric or substance-related symptoms requiring inpatient hospitalization or ambulatory detoxification
  • Unable to speak English
  • Have a potential target child who has a severe medical condition that limits their ability to interact with their mother (such as paralysis or severe weakness)
  • Children Subjects
  • Inclusion Criteria:
  • Age 5 years or younger
  • Are in their biological mother's custody OR are in custody of family with the goal of reunification with their biological mother and have permission from the child's legal guardian to participate in this study

Key Trial Info

Start Date :

December 18 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 31 2029

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT07168642

Start Date

December 18 2025

End Date

July 31 2029

Last Update

January 7 2026

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Baystate Medical Center

Springfield, Massachusetts, United States, 01199